https://newsletter.po.creamermedia.com
Deepening Democracy through Access to Information
Home / Statements RSS ← Back
Africa|Health|System
Africa|Health|System
africa|health|system
Close

Email this article

separate emails by commas, maximum limit of 4 addresses

Sponsored by

Close

Article Enquiry

HIV Vaccine Trials a breakthrough in ending the HIV/AIDS epidemic


Close

HIV Vaccine Trials a breakthrough in ending the HIV/AIDS epidemic

Should you have feedback on this article, please complete the fields below.

Please indicate if your feedback is in the form of a letter to the editor that you wish to have published. If so, please be aware that we require that you keep your feedback to below 300 words and we will consider its publication online or in Creamer Media’s print publications, at Creamer Media’s discretion.

We also welcome factual corrections and tip-offs and will protect the identity of our sources, please indicate if this is your wish in your feedback below.


Close

Embed Video

HIV Vaccine Trials a breakthrough in ending the HIV/AIDS epidemic

HIV Vaccine Trials a breakthrough in ending the HIV/AIDS epidemic

3rd February 2026

ARTICLE ENQUIRY      SAVE THIS ARTICLE      EMAIL THIS ARTICLE

Font size: -+

The content on this page is not written by Polity.org.za, but is supplied by third parties. This content does not constitute news reporting by Polity.org.za.

The Democratic Alliance (DA) is thrilled by the news of vaccine trials for HIV. While in an early trial phase, this shows South Africa's brilliant medical research capabilities. This is a moment of hope.

Our country has a deeply traumatic history with HIV/AIDS, which we have responded to with the biggest ART/ARV treatment system in the world. South Africa currently has around 8.15 million people living with HIV, and about 6.3 million of whom are on treatment, making South Africa the epicentre of the global HIV epidemic. About 1.3 million people also participate in PREP programmes, which assist in preventing contraction of HIV.

Advertisement

If successful, this vaccine has the potential to relieve major strain on the Department of Health in preventing HIV/AIDS. A successful trial would be momentous to South Africa, laying important groundwork for HIV vaccine development, research and capacity on the continent.

We wish the SA Medical Research Council, the Desmond Tutu HIV Foundation, and the Wits Health Consortium (BRILLIANT CONSORTIUM) well in this first-ever human HIV vaccine trial, which is designed and will be run by African scientists.

Advertisement

 

Issued by Michele Clarke MP - DA Spokesperson on Health

EMAIL THIS ARTICLE      SAVE THIS ARTICLE      ARTICLE ENQUIRY      FEEDBACK

To subscribe email subscriptions@creamermedia.co.za or click here
To advertise email advertising@creamermedia.co.za or click here


About

Polity.org.za is a product of Creamer Media.
www.creamermedia.co.za

Other Creamer Media Products include:
Engineering News
Mining Weekly
Research Channel Africa

Read more

Subscriptions

We offer a variety of subscriptions to our Magazine, Website, PDF Reports and our photo library.

Subscriptions are available via the Creamer Media Store.

View store

Advertise

Advertising on Polity.org.za is an effective way to build and consolidate a company's profile among clients and prospective clients. Email advertising@creamermedia.co.za

View options

Email Registration Success

Thank you, you have successfully subscribed to one or more of Creamer Media’s email newsletters. You should start receiving the email newsletters in due course.

Our email newsletters may land in your junk or spam folder. To prevent this, kindly add newsletters@creamermedia.co.za to your address book or safe sender list. If you experience any issues with the receipt of our email newsletters, please email subscriptions@creamermedia.co.za